Pasquale Viggiano | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr. Pasquale Viggiano | Medicine and Health Sciences | Best Researcher Award

Ricercatore University of Bari: Universita degli Studi di Bari Aldo Moro Italy

👨‍⚕️ Dr. Pasquale Viggiano, born on January 31, 1990, in Santa Maria Capua Vetere, Italy, is a distinguished ophthalmologist and researcher. With a robust academic background and practical expertise, he is currently a researcher in Ophthalmology at the Department of Biomedicine Translation and Neuroscience, University of Bari “Aldo Moro.”

Profile

Orcid

Education

🎓 Residency in Ophthalmology (2016-2020): University G. D’Annunzio Chieti-Pescara, Italy, guided by Prof. Leonardo Mastropasqua and Prof. Paolo Carpineto.
🎓 Medical Degree (2009-2015): Catholic University of Sacred Heart, Rome, Italy. Graduated on October 19, 2015.
🎓 Fellowship in Cataract Surgery (2023): Eye Research Center and Dr. Agarwal’s Eye Hospital, Chennai, India.

Experience

🔬 Current Position:

  • Since 2022: Researcher Ophthalmologist, University of Bari “Aldo Moro.”
    🩺 Past Roles:
  • 2021: Researcher at IRCCS-Fondazione Bietti, Rome.
  • 2014-2015: Internships in Ophthalmology and Anesthesiology at Catholic University of Sacred Heart, Rome.

Research Interests

🔍 Dr. Viggiano’s research focuses on:

  • Advanced optical coherence tomography (OCT).
  • Vascular changes in macular diseases.
  • Innovations in cataract and retinal surgery.

Awards

🏆 Nominee for excellence in clinical ophthalmology and scientific research.

Publications Top Notes:

📚 Highlighted Publications:

Borrelli E, Viggiano P et al., “In Vivo Mapping of the Choriocapillaris in Healthy Eyes.” Ophthalmology Retina, 2019. DOI.

Cited by: Numerous retinal imaging studies.

Borrelli E, Viggiano P, Mastropasqua R., “Vascular Changes in Age-Related Macular Degeneration.” Ann Eye Sci, 2019.

Cited by: Over 20 AMD-focused articles.

Boscia G, Viggiano P et al., “Choroidal Remodeling Following Different Anti-VEGF Therapies in Neovascular AMD.” Scientific Reports, 2024.

Cited by: Studies on anti-VEGF therapies.